Dermoid cyst

disease
On this page

Also known as benign cystic teratomadermoiddermoid cyst, benigndermoid tumormature cystic teratomasubcutaneous cystic teratoma

Summary

Dermoid cyst (MONDO:0002378) is a disease (an umbrella term covering 5 Mondo subtypes) and 3 clinical trials. Top therapeutic interventions include imatinib and vactosertib. A subtype of cystic teratoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 5 Mondo subtypes
  • Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namedermoid cyst
Mondo IDMONDO:0002378
MeSHD003884
DOIDDOID:2658
ICD-111622534741
NCITC9011
SNOMED CT441459009
UMLSC0011649
MedGen41504
GARD0023127
Is cancer (heuristic)no

Also known as: benign cystic teratoma · dermoid · dermoid cyst · dermoid cyst, benign · dermoid tumor · mature cystic teratoma · subcutaneous cystic teratoma

Disease family

This is a subtype of cystic teratoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmgerm cell tumornongerminomatous germ cell tumorteratomacystic teratomadermoid cyst

Related subtypes (2): ovarian cystic teratoma, adult cystic teratoma

Subtypes (5): dermoid cyst of skin, spinal cord dermoid cyst, dermoid cyst of ovary, cervical dermoid cyst, facial dermoid cyst

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified2
PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06219733PHASE2WITHDRAWNVactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF)
NCT03823833Not specifiedCOMPLETEDOocyte Freezing for Fertility Preservation in Benign Ovarian Tumors
NCT06816316Not specifiedCOMPLETEDRole of Alcohol in Prevention of Recurrence of the Accidentally Opened Angular Dermoid Cyst

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
IMATINIB41
VACTOSERTIB21
CHEMBL526732401